BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11405662)

  • 1. Protease inhibitors: synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type.
    Clare BW; Scozzafava A; Supuran CT
    J Med Chem; 2001 Jun; 44(13):2253-8. PubMed ID: 11405662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-beta-alanine hydroxamate moieties.
    Scozzafava A; Ilies MA; Manole G; Supuran CT
    Eur J Pharm Sci; 2000 Jul; 11(1):69-79. PubMed ID: 10913755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
    Scozzafava A; Supuran CT
    Bioorg Med Chem; 2000 Mar; 8(3):637-45. PubMed ID: 10732980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 May; 43(9):1858-65. PubMed ID: 10794702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors: synthesis of clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2000 Mar; 10(5):499-502. PubMed ID: 10743957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
    Supuran CT; Briganti F; Mincione G; Scozzafava A
    J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate.
    Supuran CT; Scozzafava A
    Eur J Pharm Sci; 2000 Mar; 10(1):67-76. PubMed ID: 10699384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors - part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase.
    Scozzafava A; Supuran CT
    Eur J Med Chem; 2000 Mar; 35(3):299-307. PubMed ID: 10785556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties.
    Ilies M; Banciu MD; Scozzafava A; Ilies MA; Caproiu MT; Supuran CT
    Bioorg Med Chem; 2003 May; 11(10):2227-39. PubMed ID: 12713832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.
    Santos MA; Marques S; Gil M; Tegoni M; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):233-42. PubMed ID: 14506914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative structure-activity relationship study on Clostridium histolyticum collagenase inhibitors: roles of electrotopological state indices.
    Gupta SP; Kumaran S
    Bioorg Med Chem; 2003 Jul; 11(14):3065-71. PubMed ID: 12818668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.
    Groneberg RD; Burns CJ; Morrissette MM; Ullrich JW; Morris RL; Darnbrough S; Djuric SW; Condon SM; McGeehan GM; Labaudiniere R; Neuenschwander K; Scotese AC; Kline JA
    J Med Chem; 1999 Feb; 42(4):541-4. PubMed ID: 10052961
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
    Gupta SP; Maheswaran V; Pande V; Kumar D
    J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.
    Zhang C; Lovering F; Behnke M; Zask A; Sandanayaka V; Sun L; Zhu Y; Xu W; Zhang Y; Levin JI
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3445-8. PubMed ID: 19464885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
    Hanessian S; Moitessier N; Gauchet C; Viau M
    J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
    Steinman DH; Curtin ML; Garland RB; Davidsen SK; Heyman HR; Holms JH; Albert DH; Magoc TJ; Nagy IB; Marcotte PA; Li J; Morgan DW; Hutchins C; Summers JB
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2087-92. PubMed ID: 9873491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates.
    Delaet NG; Robinson LA; Wilson DM; Sullivan RW; Bradley EK; Dankwardt SM; Martin RL; Van Wart HE; Walker KA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2101-4. PubMed ID: 12798313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.
    Robinson LA; Wilson DM; Delaet NG; Bradley EK; Dankwardt SM; Campbell JA; Martin RL; Van Wart HE; Walker KA; Sullivan RW
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2381-4. PubMed ID: 12824039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.